Zoledronic Acid in the Treatment of Breast Cancer With Minimal Residual Disease in the Bone Marrow
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Primary Breast Cancer
Interventions: DRUG: Zoledronic acid + Calcium/Vitamin D
Sponsor: Novartis Pharmaceuticals